A car plowed into a Christmas market in Magdeburg, Germany, killing two and injuring nearly 60 others. Authorities suspect ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.

COPENHAGEN: Shares in Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and ...

The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, ...

A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.

Stocks signaled another rough day of trading on Friday after the House of Representatives voted against a Trump-backed ...

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

U.S. stocks rose to turn what would have been one of the market’s worst weeks of the year into just a pretty bad one ...

Novo Nordisk A/S’s shares plummeted by 27% after its obesity treatment failed to meet expectations in a key trial. The drug ...

Evan David Seigerman, BMO managing director, joins 'Fast Money' to discuss Novo sinking on its obesity drug data.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Europe’s Stoxx 600 clocked its second straight weekly fall on Friday (Dec 20), with the healthcare sector leading losses ...